|4Sep 21, 6:06 PM ET

Payne Fletcher 4

4 · Aptose Biosciences Inc. · Filed Sep 21, 2022

Insider Transaction Report

Form 4
Period: 2022-09-19
Payne Fletcher
SR VP & Chief Fin. Officer
Transactions
  • Purchase

    Common Shares

    2022-09-19$0.68/sh+10,000$6,77510,000 total(indirect: By Trust)

Documents

2 files
  • 4
    doc1.xmlPrimary

    FORM 4

  • EX-24.2

    POWER OF ATTORNEY